NCT05916430 Screening for Autism in 9-Month-Olds by Measuring Social Visual Engagement
| NCT ID | NCT05916430 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Emory University |
| Condition | Autism |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,120 participants |
| Start Date | 2023-02-02 |
| Primary Completion | 2027-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,120 participants in total. It began in 2023-02-02 with a primary completion date of 2027-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this project is to measure the clinical utility of an objective and quantitative eye-tracking assay collected on a standalone, mobile investigational device to accurately screen 9-month-old infants for autism spectrum disorder and other actionable delays.
Eligibility Criteria
Inclusion Criteria: * Infants between the chronological ages of 8-10 months * Infants must be generally healthy with no acute illnesses likely to prevent successful or valid data collection (e.g., current vomiting, high fever, conjunctivitis affecting vision) * Participants' parents/caregivers must be able to understand and voluntarily provide written informed consent. Exclusion Criteria: \- Children will be excluded if they have signs of acute illness likely to prevent successful or valid data collection (e.g., conjunctivitis affecting vision, current vomiting, or high fever).
Contact & Investigator
Warren R Jones, PhD
PRINCIPAL INVESTIGATOR
Emory University
Frequently Asked Questions
Who can join the NCT05916430 clinical trial?
This trial is open to participants of all sexes, aged 8 Months or older, up to 10 Months, studying Autism. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05916430 currently recruiting?
Yes, NCT05916430 is actively recruiting participants. Contact the research team at FirstFocus@emory.edu for enrollment information.
Where is the NCT05916430 trial being conducted?
This trial is being conducted at Atlanta, United States, Atlanta, United States.
Who is sponsoring the NCT05916430 clinical trial?
NCT05916430 is sponsored by Emory University. The principal investigator is Warren R Jones, PhD at Emory University. The trial plans to enroll 2,120 participants.